2025-02-28 - Analysis Report
## Eli Lilly and Co. (LLY) Stock Report

**0. Executive Summary:**

Eli Lilly and Co. (LLY) is a leading pharmaceutical company.  Analysis of provided data shows significantly higher returns compared to the S&P 500 (VOO), supported by strong financial performance and positive momentum indicators. However, recent price action suggests some potential short-term volatility.

**1. Performance Comparison & Alpha/Beta Analysis:**

Eli Lilly (LLY) has exhibited substantially higher returns than the S&P 500 (VOO).  The cumulative return for LLY is 664.49%, while VOO's is 112.87%.  The difference (551.6%) is well above the historical range, placing it at the 87.4th percentile of the historical spread between the two.

The provided alpha and beta analysis showcases consistently positive alpha values (except 2015-2017) across various periods, suggesting superior risk-adjusted returns compared to the market.  The beta values indicate that LLYâ€™s price movements are generally more volatile than the overall market (but beta is less than 1 in most cases).  It's worth noting that the CAGR and market cap increased significantly over time.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 9.0% | 4.3% | -19.0% | 67.7 |
| 2016-2018  | 47.0% | 4.3% | 29.0% | 0.0 | 95.1 |
| 2017-2019  | 60.0% | 8.8% | 29.0% | 1.0 | 110.5 |
| 2018-2020  | 90.0% | 11.2% | 62.0% | 0.3 | 144.7 |
| 2019-2021  | 145.0% | 11.2% | 74.0% | 0.2 | 240.4 |
| 2020-2022  | 196.0% | 11.2% | 187.0% | 0.2 | 322.7 |
| 2021-2023  | 300.0% | 10.8% | 277.0% | 0.3 | 519.3 |
| 2022-2024  | 396.0% | 11.1% | 363.0% | 0.3 | 692.2 |
| 2023-2025  | 421.0% | 11.1% | 367.0% | 0.3 | 813.0 |


**2. Recent Price Action:**

* **Closing Price:** $905.16
* **Previous Close:** $915.01
* **Change:** -$9.85 (1.07% decrease)
* **5-day Moving Average:** $895.41
* **20-day Moving Average:** $862.15
* **60-day Moving Average:** $808.94

The price is currently below its 5-day moving average, indicating short-term bearish pressure. However, it remains above both the 20-day and 60-day moving averages, suggesting a longer-term uptrend.  The recent drop is a significant factor warranting further investigation.


**3. Technical Indicators & Expected Return:**

* **RSI:** 63.25 (Slightly above neutral; not overbought)
* **PPO:** 0.33 (Positive; indicates bullish momentum)
* **20-day Relative Strength Divergence:** +5.5 (Short-term upward trend)
* **Expected Return (2+ years):** 83.2% (Significant outperformance compared to the S&P 500)

The technical indicators suggest a generally positive outlook, but the recent price drop should be considered.  The high expected return reflects the historical outperformance against the S&P 500.


**4. Recent Earnings Analysis:**

The earnings data shows some volatility.  While Q2 and Q3 2024 show strong EPS and revenue, Q1 2024 and Q4 2023 were relatively weaker.  Further analysis is needed to determine the cause of this variation.

| Date       | EPS  | Revenue      |
|------------|------|---------------|
| 2024-10-30 | $1.08 | $11.44 B      |
| 2024-08-08 | $3.29 | $11.30 B      |
| 2024-04-30 | $2.49 | $8.77 B       |
| 2023-11-02 | -$0.06| $9.50 B       |
| 2024-10-30 | -$0.06| $9.50 B       |


**5. Financial Information:**

The financial statements show consistently high revenue and profit margins, indicating strong profitability.  ROE also displays a degree of volatility, but overall suggests a healthy return on equity.

**Revenue and Profitability:**

| Quarter | Revenue    | Profit Margin |
|---------|------------|---------------|
| 2024-12-31 | $13.53B   | 82.24%       |
| 2024-09-30 | $11.44B   | 81.02%       |
| 2024-06-30 | $11.30B   | 80.80%       |
| 2024-03-31 | $8.77B    | 80.91%       |
| 2023-12-31 | $9.35B    | 80.88%       |

**Capital and Profitability:**

| Quarter | Equity     | ROE     |
|---------|------------|---------|
| 2024-12-31 | $14.19B   | 31.07%  |
| 2024-09-30 | $14.24B   | 6.81%   |
| 2024-06-30 | $13.56B   | 21.88%  |
| 2024-03-31 | $12.81B   | 17.51%  |
| 2023-12-31 | $10.77B   | 20.33%  |


**6. Overall Analysis:**

LLY has demonstrated exceptional historical performance, significantly outperforming the S&P 500.  Strong financial fundamentals support this performance. However, recent price action suggests short-term volatility.  While the long-term outlook remains positive based on the historical data and projected returns, investors should monitor the recent price decline and upcoming earnings reports closely.  Further investigation into the reasons behind the recent price drop and the volatility in quarterly earnings is recommended before making investment decisions.
